ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.

NDAQ:PMN - Post by User

ProMIS Neurosciences Inc > Hey 4cent David.;recent PMN buy.

<< Previous

Bullboard Posts

Next >>

Comment by Mole101on Dec 16, 2021 6:39pm

125 Views

Post# 34238856

RE:Hey 4cent David.;recent PMN buy.

Nah.. not today or yesterday , but good try :)

garygp wrote: Hey David,

I know how much you enjoy tracking other investors buys especially, and sells too, so I thought I would let you know that 217,000 of my 500,000 bid got filled today leaving 283,000 to go. Why you would care is beyond me, but whatever.

M101 was right the other day; at this point there is little risk so what's to lose. Oh I know, many real market enthusiasts or well healed investors/gurus will say I'll wait and buy at 8 and 10 cents (you are probably a part of that group) but I'm just a little guy trying to make a buck and not look for perfection like some. Guess that's why I have succeeded. Good luck to you.

G.